Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
What is Genetic Engineering?00:49

What is Genetic Engineering?

74.1K
Overview
74.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era.

Pediatric transplantation·2025
Same author

The Essential Role of Medicaid in Duchenne Muscular Dystrophy Care: A Call to Protect Vulnerable Populations.

Pediatric neurology·2025
Same author

Perineuroma Caused Isolated Footdrop.

Neurology·2024
Same author

Exploring effectiveness in brain removal techniques: A comparison of approaches.

Anatomical sciences education·2023
Same author

Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis.

Acta neuropathologica·2022
Same author

Harlequin Syndrome, Apnea, and Acute on Chronic Hemiparesis: An Atypical Pediatric Case of Chiari I With Holocord Syringohydromyelia.

Pediatric neurology·2021

Related Experiment Video

Updated: Jul 2, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K

CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders.

Stephen Chrzanowski1, Ranjan Batra2

  • 1Department of Neurology, Boston Children's Hospital, Boston, Massachusetts; Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts; Division of Neuromuscular Medicine, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.

Pediatric Neurology
|February 23, 2024
PubMed
Summary

Gene editing technologies, like CRISPR, offer personalized treatments for pediatric neurological disorders by correcting mutations. Ongoing research focuses on optimizing efficiency and safety for clinical application.

Keywords:
CRISPR-Cas9Dravet syndromeDuchenne muscular dystrophyFragile X syndromeGene therapyHuntington diseaseSpinal muscular atrophyTay Sachs disease

More Related Videos

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.2K
CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer
09:39

CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer

Published on: June 9, 2018

9.8K

Related Experiment Videos

Last Updated: Jul 2, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K
Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.2K
CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer
09:39

CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer

Published on: June 9, 2018

9.8K

Area of Science:

  • Genetics and Genomics
  • Neurology
  • Biotechnology

Background:

  • Gene editing technologies present novel therapeutic avenues for pediatric neurological disorders.
  • CRISPR-based systems offer specificity, versatility, and cost-effectiveness for personalized gene therapy.
  • Current challenges include optimizing editing efficiency, minimizing off-target effects, and managing immune responses.

Purpose of the Study:

  • To review the fundamentals of CRISPR-based gene therapies for pediatric neurological disorders.
  • To discuss the opportunities and challenges associated with these emerging therapies.
  • To highlight preclinical advancements in applying CRISPR to specific pediatric neurological diseases.

Main Methods:

  • Review of current literature on CRISPR-Cas gene editing technologies.
  • Analysis of preclinical studies focusing on pediatric neurological conditions.
  • Discussion of the potential clinical applications, benefits, and risks of CRISPR-based therapies.

Main Results:

  • CRISPR technology enables precise correction of dysfunctional mutations or modulation of gene expression.
  • Significant preclinical progress has been made in various pediatric neurological diseases.
  • Optimization of editing efficiency and safety profiles are critical for clinical translation.

Conclusions:

  • CRISPR-based gene therapies hold immense promise for treating pediatric neurological disorders.
  • Understanding the benefits and risks is crucial for clinicians.
  • Further research and development are necessary to overcome existing challenges and enable widespread clinical use.